Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3711847 | 1.00 | MAPT (0.39) | MAPTHSD17B10ALDH1A1L3MBTL1CYP2C19 | |
| SCHEMBL155552 | 1.00 | MAPT (0.39) | MAPTHSD17B10ALDH1A1L3MBTL1CYP2C19 | |
| SCHEMBL1565454 | 0.97 | MAPT (0.40) | MAPTHSD17B10ALDH1A1L3MBTL1CYP2C19 | |
| SCHEMBL2575625 | 0.87 | HSD17B10 (0.41) | MAPTHSD17B10ALDH1A1L3MBTL1CYP2C19 | |
| SCHEMBL9815742 | 0.87 | HSD17B10 (0.41) | MAPTHSD17B10ALDH1A1L3MBTL1CYP2C19 | |
| SCHEMBL2573906 | 0.87 | HSD17B10 (0.41) | MAPTHSD17B10ALDH1A1L3MBTL1CYP2C19 | |
| SCHEMBL10898902 | 0.81 | MAPT (0.30) | MAPT | |
| SCHEMBL670072 | 0.78 | HSD17B10 (0.38) | MAPTHSD17B10ALDH1A1L3MBTL1HSD11B1 | |
| SCHEMBL14837179 | 0.78 | HSD17B10 (0.38) | MAPTHSD17B10ALDH1A1L3MBTL1HSD11B1 | |
| SCHEMBL2575627 | 0.78 | HSD17B10 (0.36) | MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11267953-B2 | Iso(thio)cyanate composition, and resin composition including same for optical member | HOYA LENS THAILAND LTD. (TH) | 2022-03-08 | — | — | US | disclosed |
| EP-3957666-A1 | ISO(THIO)CYANATE COMPOSITION, AND RESIN COMPOSITION INCLUDING SAME FOR OPTICAL MEMBER | Hoya Lens Thailand Ltd. (TH) | 2022-02-23 | — | — | EP | disclosed |
| EP-3269749-B1 | ISO(THIO)CYANATE COMPOSITION, AND RESIN COMPOSITION INCLUDING SAME FOR OPTICAL MEMBER | HOYA LENS THAILAND LTD (TH) | 2021-12-01 | — | — | EP | disclosed |
| US-20200123345-A1 | ISO(THIO)CYANATE COMPOSITION, AND RESIN COMPOSITION INCLUDING SAME FOR OPTICAL MEMBER | HOYA LENS THAILAND LTD. (TH) | 2020-04-23 | — | — | US | disclosed |
| US-10544283-B2 | Iso(thio)cyanate composition, and resin composition including same for optical member | HOYA LENS THAILAND LTD. (TH) | 2020-01-28 | — | — | US | disclosed |
| US-20180037722-A1 | ISO(THIO)CYANATE COMPOSITION, AND RESIN COMPOSITION INCLUDING SAME FOR OPTICAL MEMBER | HOYA LENS THAILAND LTD. (TH) | 2018-02-08 | — | — | US | disclosed |
| EP-3269749-A1 | ISO(THIO)CYANATE COMPOSITION, AND RESIN COMPOSITION INCLUDING SAME FOR OPTICAL MEMBER | Hoya Lens Thailand Ltd. (TH) | 2018-01-17 | — | — | EP | disclosed |
| US-20120190811-A1 | PROCESS FOR THE PREPARATION OF AN ALLYL ALKYL ETHER BY CATALYTIC ALLYLATION | HEXION INC. (FORMERLY KNOWN AS MOMENTIVE SPECIALTY CHEMICALS INC.) | 2012-07-26 | — | — | US | disclosed |
| EP-2393767-A1 | PROCESS FOR THE PREPARATION OF AN ALLY ALKYL EHTER BY CATALYTIC ALLYATION | Momentive Specialty Chemicals Research Belgium S.A. (BE) | 2011-12-14 | — | — | EP | disclosed |
| WO-2010086139-A1 | PROCESS FOR THE PREPARATION OF AN ALLY ALKYL EHTER BY CATALYTIC ALLYATION | RESOLUTION RESEARCH NEDERLAND B.V. (NL) | 2010-08-05 | — | — | WO | disclosed |
| EP-2213644-A1 | Process for the preparation of an allyl alkyl ether by catalyic allylation | Hexion Specialty Chemicals Research Belgium S.A. (BE) | 2010-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190811-A1 | PROCESS FOR THE PREPARATION OF AN ALLYL ALKYL ETHER BY CATALYTIC ALLYLATION | ALOX5, APEH, ALKBH5 | MAPT 4637/4885HSD17B10 818/4885ALDH1A1 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.